Dr. Robert Mittendorff
B Capital
General Partner
San Fransisco, California

()

Category: Emerging Growth
Mark: AA

Comments are closed.

Biography

Dr. Robert Mittendorff is a General Partner and Global Head of Healthcare at B Capital, where he leads venture and growth investments in category-defining healthcare companies. At B Capital, he has invested in and serves on the board of companies such as CapitalRx, Carlsmed, Nalu Medical, Lively, Triumvira, Atomwise, and Carrick, among others.


Previously, Robert spent nearly a decade at Norwest Venture Partners as Partner and Co-Head of Healthcare. He has been involved in investments and associated exits with public equity value or acquisition value exceeding $10 billion. He is a board-certified emergency physician and former public company operating executive with experience spanning investing, complex business development transactions, the leadership of clinical advisory boards, product development, clinical trials, commercial activities, and clinical services management. He is a Fellow of the American Academy of Emergency Medicine (FAAEM).


Robert has extensive board experience as both a director and observer at companies including Impel Neuropharma, Avalyn Pharma, Qventus, VisitPay, TigerConnect, Neocis, Talkspace, Omada, Route92, Silk Road Medical (SILK), iCardiac (acq. by eResearch), Telcare (acq. by BioTelemetry), Intersect ENT (Nasdaq: XENT), and iRhythm Technologies (Nasdaq: IRTC).


Awards

Top Healthcare Investors: 2026, 2025, 2024, 2023